LEGN Stock Analysis: Buy, Sell, or Hold?

LEGN - Legend Biotech Corporation American Depositary Shares

Pharmaceutical Preparations
$28.67
0.41 (1.45%) ▲
5d: -1.0%
30d: +53.4%
90d: +54.64%
HOLD
MODERATE Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 19, 2026 4d

Get Alerted When LEGN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: LEGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$54.53
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$33.86
15.3% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: LEGN is currently trading at $28.67, which is considered extended relative to its 30-day fair value range of $19.65 to $27.12. From a valuation perspective, the stock is trading at a discount (Forward PE: 25.6) compared to its historical average (42.3). Remarkably, the market is currently pricing in an annual earnings decline of 15.4% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, LEGN is in a uptrend. Immediate support is located at $22.42, while resistance sits at $30.41.

Market Sentiment: LEGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $57.23 (+99.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $19.65 - $27.12
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.1%

All Signals

  • BEARISH: Price extended above range (+5.7% above its trading range)
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 99.6% below Wall St target ($57.23)

Trading Range Analysis

30-Day Trading Range $19.65 - $27.12
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $22.42
Resistance Level $30.41
Current Trend Uptrend
Technical data as of May 13, 2026

Fundamental Context

Forward P/E (Next Year Est.) 25.60
Wall Street Target $57.24 (+99.6%)
Revenue Growth (YoY) 56.4%
Profit Margin -22.0%
Valuation Discount vs History -15.4% cheaper
PE vs Historical 25.6 vs 42.3 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -15.4% (market-implied from PE analysis)
1-Year Target $25.80 (-10%)
2-Year Target $23.22 (-19%)
3-Year Target $20.90 (-27%)
3-Yr Target (if PE normalizes) (PE: 26→42) $34.54 (+21%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 25.6, Growth: 1706.5%) $96.76 (+238%)
Base: (SPY PE: 22.0, Growth: 1706.5%) $83.31 (+191%)
Bear: (PE: 18.7, Growth: 1706.5%) $70.81 (+147%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.6 to 42.3
Stabilization Target: $47.38 (+65.2%)
PE Expansion Potential: +65.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 14, 2026 9:46 AM ET
Data refreshes hourly during market hours. Next update: 10:46 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ying Huang SELL 9936 shares 2026-03-25

Unlock Insider Activity

See real-time buying/selling by company executives for LEGN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$91 60 HOLD
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$101 63 BUY
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$30 56 HOLD
BHVN
Biohaven Pharmaceutical …
STRONG BUY
16 analysts
$22 57 HOLD

More Analysis for LEGN

LEGN Technical Chart LEGN Price Prediction LEGN Earnings Date LEGN Investment Advisor LEGN Fair Price Analyzer LEGN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals